Τίτλος:
Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Δεν υπάρχει περίληψη
Συγγραφείς:
Kastritis, E.
Leblond, V.
Dimopoulos, M.A.
Kimby, E.
Staber, P.
Kersten, M.J.
Tedeschi, A.
Buske, C.
Περιοδικό:
Annals of Oncology
Εκδότης:
Oxford University Press
Λέξεις-κλειδιά:
bendamustine; bortezomib; rituximab; antineoplastic agent; chemokine receptor CXCR4; CXCR4 protein, human; MYD88 protein, human; myeloid differentiation factor 88, Article; asymptomatic disease; cancer diagnosis; cancer epidemiology; cancer incidence; cancer recurrence; cancer staging; cancer survival; clinical evaluation; combination drug therapy; histopathology; human; long term care; medical history; personalized medicine; prevalence; priority journal; risk assessment; treatment indication; treatment response; Waldenstroem macroglobulinemia; aftercare; asymptomatic disease; autotransplantation; bone marrow; Europe; genetics; incidence; medical society; oncology; onset age; pathology; plasmapheresis; practice guideline; procedures; stem cell transplantation; survivorship; treatment outcome; tumor recurrence; Waldenstroem macroglobulinemia, Aftercare; Age of Onset; Antineoplastic Combined Chemotherapy Protocols; Asymptomatic Diseases; Bone Marrow; Europe; Humans; Incidence; Medical Oncology; Myeloid Differentiation Factor 88; Neoplasm Recurrence, Local; Neoplasm Staging; Plasmapheresis; Precision Medicine; Receptors, CXCR4; Societies, Medical; Stem Cell Transplantation; Survivorship; Transplantation, Autologous; Treatment Outcome; Waldenstrom Macroglobulinemia
DOI:
10.1093/annonc/mdy146
